[ad_1]
A priori, the restriction will affect the Russian population, vaccinated with the local drug produced by the Gamaleya laboratory, but also inhabitants of many countries who have come to Moscow to vaccinate their population, among them, Argentina, which was one of the first nations to acquire Sputnik V and is currently producing a local version of this vaccine.
Have the magnitude of the circumstances, The Post noted that around 300,000 Russians visited the United States in 2019, the latest year for which figures are available, according to the US Travel Association.
The event appears to be a new chapter in the strained diplomatic relations between Washington and Moscow, a mutual distrust that developed in the heat of the Cold War and remains latent in the days of Joe Biden and Vladimir Putin.
From Russia, the Russian Direct Investment Fund (RDIF), the sovereign wealth fund that backed Sputnik V, said the vaccine “Not only has it been approved in 70 countries where more than 4 billion people live, or more than half of the world’s population, its efficacy and safety have been confirmed both in clinical trials and during its use in the real world in several countries “.
For their part, the American vaccines from Pfizer and Moderna, as well as the Chinese vaccines Sinovac and Sinopharm have the necessary approval to authorize the entry of people immunized with them.
Source link